Company profile for Altum Pharmaceuticals

NEW Drugs in Dev: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Formed in 2016, Altum is headquartered in Vancouver, British Columbia, Canada. Altum’s philosophy is that there are many under-served areas in oncology, especially in pre-cancerous conditions and cancer related complications. Therapeutics developed for these areas often have applications in the same organs but for non-cancer conditions, expanding the market potential for these drugs. Altum’s focus is to develop these innov...
Formed in 2016, Altum is headquartered in Vancouver, British Columbia, Canada. Altum’s philosophy is that there are many under-served areas in oncology, especially in pre-cancerous conditions and cancer related complications. Therapeutics developed for these areas often have applications in the same organs but for non-cancer conditions, expanding the market potential for these drugs. Altum’s focus is to develop these innovative products to address under-served conditions with potential to treat broader medical conditions. Shortly after its formation, Altum acquired the BiPhasix™ platform from Helix Biopharma.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
1055 West Georgia Street, Suite 2100 P.O. Box 11110, Royal Centre Vancouver, B...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.clinicaltrialsarena.com/news/betterlife-inhaled-therapy-trial-chile/

CLINICALTRIALSARENA
30 Nov 2021

https://www.globenewswire.com/news-release/2021/03/11/2191338/0/en/BetterLife-Subsidiary-Altum-Pharmaceuticals-to-Conduct-Randomized-Placebo-controlled-COVID-19-Trial-Using-AP-003.html#:~:text=(%E2%80%9CBetterLife%E2%80%9D%20or%20the%20%E2%80%9C,%E2%80%9D)%20in%20COVID%2D19%20patients

GLOBENEWSWIRE
11 Mar 2021

https://www.prnewswire.com/news-releases/betterlife-pharma-updates-shareholders-on-its-proposed-acquisition-of-altum-301074192.html

PRNEWSWIRE
11 Jun 2020

https://www.prnewswire.com/news-releases/betterlife-pharma-updates-shareholders-on-its-proposed-acquisition-of-altum-301074192.html

PRNEWSWIRE
10 Jun 2020

https://www.otcmarkets.com/stock/PVOTF/news/BetterLife-Pharma-Updates-Shareholders-on-its-Proposed-Acquisition-of-Altum?id=263873

OTCMARKETS
04 Jun 2020

https://www.prnewswire.com/news-releases/betterlife-pharma-updates-shareholders-on-its-proposed-acquisition-of-altum-301070523.html

PRNEWSWIRE
04 Jun 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty